Diet-induced models for obesity and type 2 diabetes

Drug Discovery Today: Disease Models

Volumn 4, Issue 1, 2007, Pages 3-8

  Reuter, Tanja Y ^a  

^a MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ANTIDIABETIC AGENT; FIBRIC ACID DERIVATIVE; FISH OIL; FRUCTOSE; GLITAZONE DERIVATIVE; METFORMIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL FOOD; CALORIC INTAKE; CARBOHYDRATE INTAKE; DEVELOPED COUNTRY; DIET SUPPLEMENTATION; DIETARY INTAKE; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE; LIPID DIET; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; RISK FACTOR; SITTING; STREPTOZOCIN DIABETES;

EID: 37349095003     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.09.004     Document Type: Review

References (38)

1. Haslam D.W., et al. Obesity. Lancet 366 (2005) 1197-1209
2. Bouchard C., et al. Genetics of obesity. Ann. Rev. Nutr. 13 (1993) 337-354
3. Lephart E.D., et al. Behavioral effects of endocrine-disrupting substances: Phytoestrogens. ILAR J. 45 (2004) 443-454
4. Ramirez I. Feeding a liquid diet increases energy intake, weight gain and body fat in rats. J. Nutr. 117 (1987) 2127-2134
5. Kanarek R.B., et al. Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats. J. Nutr. 112 (1982) 1254-1546
6. Surwit R.S., et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44 (1995) 645-651
7. Parekh P.I., et al. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 47 (1998) 1089-1096
8. Winzell M.S., et al. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (2004) S215-S219
9. Surwit R.S., et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4061-4065
10. Collins S., et al. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138 (1997) 405-413
11. Ahren B., et al. Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice. Eur. J. Pharmacol. 404 (2000) 239-245
12. Audrey L., et al. Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice. Eur. J. Pharmacol. 462 (2003) 125-132
13. Sclafani A., et al. Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol. Behav. 17 (1976) 461-471
14. Chang S., et al. Metabolic differences between obesity-prone and obesity-resistant rats. Am. J. Physiol. 259 (1990) R1103-R1110
15. Farley C., et al. Meal pattern analysis of diet-induced obesity in susceptible and resistant rats. Obes. Res. 11 (2003) 845-851
16. Levin B.E. Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats. Am. J. Physiol. 270 (1996) R456-R461
17. Levin B.E., et al. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol. 273 (1997) R725-R730
18. Oakes N.D., et al. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46 (1997) 1768-1774
19. Storlien L.H., et al. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40 (1991) 280-289
20. Ricci M.R., et al. Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285 (2003) R610-R618
21. Levin B.E., et al. A new obesity-prone, glucose intolerant rat strain (F.DIO). Am. J. Physiol. 285 (2003) R1184-R1191
22. Levin B.E., et al. The F-DIO obesity-prone rat is insulin resistant prior to obesity onset. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289 (2005) R704-R711
23. Srinivasan K., et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52 (2005) 313-320
24. Reed M.J., et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49 (2000) 1390-1394
25. Hermanowski-Vosatka A., et al. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 202 (2005) 517-527
26. Zavaroni I., et al. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29 (1980) 970-973
27. Park O.J., et al. Mechanisms of fructose-induced hypertriglyceridemia in the rat. Biochem. J. 282 (1992) 753-757
28. Nakagawa T., et al. A causal role to uric acid in fructose induced metabolic syndrome. Am. J. Physiol. Renal. Physiol. 290 (2006) F625-F631
29. Song D., et al. Chronic N-Acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur. J. Pharmacol. 508 (2005) 205-210
30. Inoue I., et al. Effect of Troglitazone (CS-045) and Bezafibrate on glucose tolerance, liver glycogen synthase activity and ß-Oxidation in fructose-fed rats. Metabolism 44 (1995) 1626-1630
31. Rothwell N.J., et al. The cafeteria diets as a tool for studies of thermogenesis. J. Nutr. 118 (1988) 925-928
32. Prats E., et al. Energy intake of rats fed a cafeteria diet. Physiol. Behav. 45 (1989) 263-272
33. Kretschmer B.D., et al. Modulatory role of food, feeding regime and physical exercise on body weight and insulin resistance. Life Sci. 76 (2005) 1553-1573
34. Dietschy J.M., et al. Role of liver in the maintenance of cholesterol and low density lipoproteins in different animal species, including man. J. Lipid. Res. 34 (1993) 1637-1659
35. Bravo E., et al. Why prefer the golden Syrian hamster (Mesocricetus auratus) to the Wistar rat in experimental studies on plasma lipoprotein metabolism?. Comp. Biochem. Phsyiol. 107B (1994) 347-355
36. Wang P.R., et al. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists. Eur. J. Pharmacol. 427 (2001) 285-293
37. Mittelman S.D., et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes 49 (2000) 2116-2125
38. Hoenig M., et al. The cat as a model for human nutrition and disease. Curr. Opin. Clin. Nutr. Metab. Care 5 (2006) 584-588